Anzeige
Mehr »
Donnerstag, 26.06.2025 - Börsentäglich über 12.000 News
Ein echter Gamechanger: Diese News kann den Grundstein für eine Neubewertung der Rock-Tech-Aktie legen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CMH3 | ISIN: SE0015661152 | Ticker-Symbol: 7ZT
Stuttgart
26.06.25 | 14:07
0,345 Euro
+20,67 % +0,059
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
HAMLET BIOPHARMA AB Chart 1 Jahr
5-Tage-Chart
HAMLET BIOPHARMA AB 5-Tage-Chart

Aktuelle News zur HAMLET BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiHamlet BioPharma AB (publ): Hamlet BioPharma Holds Successful In Person Meeting with US FDA243LUND, Sweden, June 25, 2025 /PRNewswire/ -- Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections...
► Artikel lesen
MiHAMLET BIOPHARMA AB: Hamlet BioPharma Holds Successful In Person Meeting with US FDA3
17.06.HAMLET BIOPHARMA AB: Hamlet BioPharma announces progress in Tuberculosis therapy1
17.06.HAMLET BIOPHARMA AB: Hamlet BioPharma invites to investor meeting on the 18th of June2
22.05.HAMLET BIOPHARMA AB: Q3 INTERIM REPORT JANUARY - MARCH 20252
HAMLET BIOPHARMA Aktie jetzt für 0€ handeln
19.05.HAMLET BIOPHARMA AB: Scientific Breakthrough in Alpha1H's Mechanism of Action2
22.04.HAMLET BIOPHARMA AB: Hamlet BioPharma invites to investor meeting on the 23rd of April2
08.04.HAMLET BIOPHARMA AB: New discoveries in infection biology, highlighting the rich potential of non-antibiotic treatments of infections2
08.04.HAMLET BIOPHARMA AB: New scientific advances for Alpha1H highlight the unique discovery pipeline and drug development potential for the treatment of bladder cancer1
07.04.HAMLET BIOPHARMA AB: New granted patents added to Hamlet BioPharma's extensive patent portfolio in cancer and infection2
07.04.HAMLET BIOPHARMA AB: Strong Alpha1H treatment effects confirmed in patients with bladder cancer, in final analysis. Clinical study report is being completed for submission to the FDA1
20.02.HAMLET BIOPHARMA AB: The board of Hamlet BioPharma proposes licensing agreement with Linnane Pharma, which creates conditions for an effective commercialization of Bamlet and positive value for both companies2
19.02.HAMLET BIOPHARMA AB: Elisabeth Parker appointed as Business development expert in Hamlet BioPharma and joins the team on March 3rd1
18.02.HAMLET BIOPHARMA AB: Catharina Svanborg appointed as CEO and assumes the position immediately, board member Magnus Nylén acting Chairman1
13.02.HAMLET BIOPHARMA AB: Q2 Interim Report October 2024 - December 20242
10.01.HAMLET BIOPHARMA AB: Invitation to monthly digital events and presentations of quarterly report1
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1